LUP Statistics
Record
- Title
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
- Type
- Journal Article
- Publ. year
- 2013
- Author/s
- Legendre, C. M.; Licht, C.; Muus, P.; Greenbaum, L. A. et al.
- Department/s
- Paediatrics (Lund); Pediatric Nephrology
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 1218 | 16 | 0 |
United States of America  |
320 (26%) |
Germany  |
222 (18%) |
China  |
214 (18%) |
France  |
66 (5%) |
United Kingdom of Great Britain and Northern Ireland  |
60 (5%) |
Hong Kong (China)  |
51 (4%) |
India  |
31 (3%) |
Canada  |
18 (1%) |
Singapore  |
13 (1%) |
Japan  |
13 (1%) |
Netherlands (Kingdom of the)  |
13 (1%) |
Italy  |
12 (1%) |
Sweden  |
12 (1%) |
Australia  |
11 (1%) |
Ireland  |
11 (1%) |
Spain  |
11 (1%) |
Brazil  |
11 (1%) |
Taiwan (China)  |
9 (1%) |
Turkiye  |
8 (1%) |
Argentina  |
8 (1%) |
Poland  |
6 (0%) |
Belgium  |
6 (0%) |
Pakistan  |
5 (0%) |
Ukraine  |
5 (0%) |
Unknown  |
4 (0%) |
Portugal  |
4 (0%) |
Russian Federation  |
4 (0%) |
Iran  |
4 (0%) |
Saudi Arabia  |
4 (0%) |
Switzerland  |
3 (0%) |
Chile  |
3 (0%) |
Romania  |
3 (0%) |
South Korea  |
3 (0%) |
Colombia  |
3 (0%) |
Czechia  |
3 (0%) |
Israel  |
2 (0%) |
Egypt  |
2 (0%) |
Croatia  |
2 (0%) |
Bulgaria  |
2 (0%) |
South Africa  |
2 (0%) |
Norway  |
2 (0%) |
Denmark  |
2 (0%) |
Indonesia  |
2 (0%) |
Viet Nam  |
2 (0%) |
Lebanon  |
2 (0%) |
Algeria  |
2 (0%) |
Latvia  |
1 (0%) |
Morocco  |
1 (0%) |
Costa Rica  |
1 (0%) |
Philippines  |
1 (0%) |
Qatar  |
1 (0%) |
Lithuania  |
1 (0%) |
Kyrgyzstan  |
1 (0%) |
Kuwait  |
1 (0%) |
Macedonia  |
1 (0%) |
Jersey  |
1 (0%) |
Mexico  |
1 (0%) |
Ghana  |
1 (0%) |
Iraq  |
1 (0%) |
Finland  |
1 (0%) |
Cambodia  |
1 (0%) |
Asia-Pacific location  |
1 (0%) |
Tunisia  |
1 (0%) |
Serbia  |
1 (0%) |
United Arab Emirates  |
1 (0%) |
Austria  |
1 (0%) |
Hungary  |
1 (0%) |
Mongolia  |
1 (0%) |